Skip to main content
    I

    Icecure Medical (ICCM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.83
    +0.07 (+9.21%)

    Market Cap: $3.39M

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Icecure Medical (ICCM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Icecure Medical (ICCM) has a market cap of $3.39M. It kept -427.67% of revenue as net income over the last 12 months. Revenue grew 41.62% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$3.39M
    Latest price (Nov 17, 2026)$0.83

    Key Dates

    The next earnings report is set for Nov 18, 2026, before the open.

    Next Earnings DateNov 18, 2026, before the open
    Last Earnings DateAug 12, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    Sales and book value multiples are 0.6x and 0.2x. Its year-end P/S ranged from 11.7x to 24.2x from 2022 to 2025.

    P/S Ratio0.6x
    Forward P/S0.8x
    P/B Ratio0.2x

    Valuation history and multiples

    Price Statistics

    The stock is down 96.12% over 52 weeks and trades 35.66% below its 50-day average.

    Beta (1Y)1.20
    52-Week Change-96.12%
    1-Month Change-23.14%
    3-Month Change-67.06%
    6-Month Change-87.86%
    5-Year Change-99.60%
    10-Year Change-85.51%
    Total Return (1Y)-96.12%
    Total Return (3Y CAGR)-66.55%
    Total Return (5Y CAGR)-66.17%
    Max Drawdown (1Y)-96.89%
    Max Drawdown (3Y)-98.54%
    Sharpe Ratio (1Y)-2.02
    Correlation with SPY (1Y)0.10
    50-Day Average$1.29
    200-Day Average$6.81
    52-Week Range$0.65 to $22.50
    RSI (14 Days)39.3
    Average Volume (20 Days)126.37K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.87x current liabilities.

    Current Ratio2.87x
    Quick Ratio2.44x
    Interest Coverage-106.52x

    Returns and Efficiency

    Return on equity is -141.90% and return on assets is -95.33% over the last 12 months.

    Return on Equity (ROE)-141.90%
    Return on Assets (ROA)-95.33%
    Return on Capital Employed (ROCE)-140.33%
    ROA (5Y Average)-81.28%
    Asset Turnover0.28x
    Inventory Turnover0.97x
    Receivables Turnover11.49x
    Cash Conversion Cycle218 days

    Scores

    ICCM has an Altman Z-Score of -12.11, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-12.11
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $3.95M over the last 12 months.

    Revenue$3.95M
    Revenue Growth (YoY)+41.62%
    Gross Profit$1.43M
    Operating Income-$21.96M
    Pretax Income-$16.88M
    Net Income-$16.88M
    EBITDA-$16.44M
    EBIT-$16.72M
    Reported EPS (TTM)-$6.77

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.19% of the $17.71M in total assets.

    Cash and Equivalents$12.03M
    Working Capital$10.86M
    Shareholder Equity$11.90M
    Book Value Per Share$3.85
    Total Assets$17.71M
    Total Liabilities$5.81M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $69.77K of capital spending, operating cash flow left -$16.39M of free cash flow.

    Operating Cash Flow-$16.32M
    Capital Expenditures$69.77K
    Free Cash Flow-$16.39M
    FCF Per Share-$3.53
    Depreciation and Amortization$284.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -556.35%.

    Gross Margin36.10%
    Operating Margin-556.35%
    Pretax Margin-427.67%
    Net Margin-427.67%
    EBITDA Margin-416.49%
    EBIT Margin-423.69%
    FCF Margin-415.23%
    Gross Margin (5Y Average)44.10%

    Growth

    Revenue grew 3.08% a year over 3 years.

    Revenue Growth (3Y CAGR)+3.08%
    Revenue Growth (5Y CAGR)-2.67%

    Revenue and profit by year

    Dividends and Yields

    ICCM does not pay a dividend. Its free cash flow yield is -639.62%.

    FCF Yield-639.62%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-30 reverse split on Jun 4, 2026.

    Last Split DateJun 4, 2026
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 7 similar companies, ICCM has the 4th highest P/S.

    P/S Ratio0.6x vs 0.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+41.62% vs +36.55% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 61.41% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+61.41%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ICCM

    What is ICCM's market cap?

    Icecure Medical has a market cap of $3.39M.

    How many shares of ICCM are outstanding?

    Icecure Medical has 3.09M shares outstanding.

    Does ICCM pay a dividend?

    No. Icecure Medical does not pay a dividend.